| Computer-aided diagnosis with a convolutional neural network algorithm for automated detection of urinary tract stones on plain X-ray M Kobayashi, J Ishioka, Y Matsuoka, Y Fukuda, Y Kohno, K Kawano, ... BMC urology 21, 1-10, 2021 | 17 | 2021 |
| Effectiveness and safety profile of pembrolizumab for metastatic urothelial cancer: A retrospective single‐center analysis in Japan M Fujiwara, T Yuasa, T Urasaki, Y Komai, R Fujiwara, N Numao, ... Cancer Reports 4 (6), e1398, 2021 | 13 | 2021 |
| Case report: a case of trimethoprim/sulfamethoxazole-triggered hypotensive shock: cytokine release syndrome related to immune checkpoint inhibitors and drug-induced … T Urasaki, M Ono, T Mochizuki, K Takeda, A Nishizawa, E Fukagawa, ... Frontiers in Oncology 11, 681997, 2021 | 12 | 2021 |
| Modified Glasgow prognostic score as a predictor of prognosis in metastatic renal cell carcinoma treated with nivolumab R Fujiwara, K Takemura, M Fujiwara, T Yuasa, S Yasuoka, Y Komai, ... Clinical Genitourinary Cancer 19 (2), e78-e83, 2021 | 11 | 2021 |
| Diagnostic value of the vesical imaging-reporting and data system in bladder urothelial carcinoma with variant histology Y Arita, S Yoshida, K Shigeta, TC Kwee, H Edo, N Okawara, M Hashimoto, ... European urology oncology 6 (1), 99-102, 2023 | 7 | 2023 |
| Switching patients with prostate cancer from GnRH antagonist to long-acting LHRH agonist for androgen deprivation: reducing hospital visits during the coronavirus pandemic M Fujiwara, T Yuasa, Y Komai, R Fujiwara, T Oguchi, N Numao, ... Cancer Diagnosis & Prognosis 1 (1), 1, 2021 | 6 | 2021 |
| Efficacy, prognostic factors, and safety profile of enzalutamide for non-metastatic and metastatic castration-resistant prostate cancer: A retrospective single-center analysis … M Fujiwara, T Yuasa, Y Komai, N Numao, S Yamamoto, I Fukui, J Yonese Targeted Oncology 15 (5), 635-643, 2020 | 6 | 2020 |
| Early serum and hematological responses to pembrolizumab therapy as predictors of survival in metastatic urothelial cancer M Fujiwara, R Fujiwara, T Urasaki, T Oguchi, Y Komai, N Numao, ... Anticancer Research 42 (4), 2045-2051, 2022 | 5 | 2022 |
| First‐line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical … M Fujiwara, H Tanaka, T Yuasa, Y Komai, T Oguchi, R Fujiwara, N Numao, ... International Journal of Urology 28 (9), 920-926, 2021 | 5 | 2021 |
| Pembrolizumab for a patient with metastatic castration‐resistant prostate cancer with microsatellite instability‐high M Fujiwara, Y Komai, T Yuasa, N Numao, S Yamamoto, I Fukui, J Yonese IJU Case Reports 3 (2), 62-64, 2020 | 5 | 2020 |
| Preoperative inferior vena cava filter implantation to prevent pulmonary fat embolism in a patient showing renal angiomyolipoma extension into the renal vein: A case report and … M Fujiwara, N Kawamura, T Okuno Journal of Rural Medicine 13 (2), 181-184, 2018 | 5 | 2018 |
| Prostate and metastasis diffusion volume based on apparent diffusion coefficient as a prognostic factor in Hormone-naïve prostate Cancer M Fujiwara, S Yoshida, T Takahara, T Soma, Y Nakamura, Y Ishikawa, ... Clinical & Experimental Metastasis 40 (2), 187-195, 2023 | 4 | 2023 |
| Significance of dorsal bladder neck involvement in predicting the progression of non‐muscle‐invasive bladder cancer Y Nakamura, H Fukushima, K Yoshitomi, T Soma, M Kobayashi, B Fan, ... International Journal of Urology 30 (4), 381-388, 2023 | 4 | 2023 |
| External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate … E Fukagawa, S Yamamoto, S Ohde, KK Yoshitomi, K Hamada, Y Yoneoka, ... International Journal of Clinical Oncology 26 (9), 1736-1744, 2021 | 4 | 2021 |
| Cisplatin, gemcitabine, and paclitaxel as a salvage second-line therapy for metastatic germ-cell cancer M Fujiwara, T Hayashi, H Takeda, T Yuasa, Y Komai, N Numao, ... Clinical Genitourinary Cancer 19 (1), e6-e11, 2021 | 4 | 2021 |
| Renal function after bladder‐preserving therapy for patients with muscle‐invasive bladder cancer: results of selective bladder‐preserving tetramodality therapy consisting of … M Toide, M Yokoyama, M Fujiwara, T Kijima, K Saito, Y Fujii International Journal of Urology 26 (10), 2019 | 4 | 2019 |
| Geriatric nutritional risk index as a predictor of prognosis in metastatic renal cell carcinoma treated with nivolumab R Fujiwara, T Yuasa, S Yamamoto, M Fujiwara, K Takemura, T Urasaki, ... Nutrition and Cancer 75 (2), 670-677, 2023 | 3 | 2023 |
| Clinical outcome and prognostic variables of second-line therapy for patients with castration-resistant prostate cancer after failure of first-line androgen receptor axis … M Fujiwara, R Fujiwara, T Oguchi, Y Komai, N Numao, S Yamamoto, ... Anticancer Research 42 (4), 2123-2130, 2022 | 3 | 2022 |
| Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancer M Fujiwara, T Yuasa, S Yasuoka, Y Komai, T Oguchi, R Fujiwara, ... Cancer Chemotherapy and Pharmacology 88 (3), 525-531, 2021 | 3 | 2021 |
| Intraoperative only versus extended duration use of antimicrobial prophylaxis for infectious complications in radical cystectomy with intestinal urinary diversion N Numao, R Fujiwara, S Uehara, S Yasuoka, M Fujiwara, Y Komai, ... Urologia Internationalis 104 (11-12), 954-959, 2020 | 3 | 2020 |
